So the outcome will be one of two worlds. One is t

So the outcome will be one of two worlds. One is the remdesivir world where BP has a drug that doesn't work, but they don't give a shit because if it doesn't work, one needs to keep taking it.

The other is the Leronlimab world. This is where LL is "the" go to drug, but it isn't perfect. It works 82% of the time and the question becomes why is not working the other 18%. And this is the part my Dad, who was the premiere bone pathologist in the world before he died, would have loved. In finding out why LL doesn't do the job in 18%, we find the key to all immune response disease. The answer and the passion for me is in the science.